The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:73
|
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Identification of a novel macrophage-related prognostic signature in colorectal cancer
    Lin, Dongfa
    Zheng, Tingjin
    Huang, Shangyuan
    Liu, Rui
    Guan, Shuwen
    Zhang, Zhishan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [42] Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
    Liu, Shuzhen
    Cao, Qing
    An, Guoyan
    Yan, Bianbian
    Lei, Lei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 17
  • [43] Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
    Salazar, Ramon
    Roepman, Paul
    Capella, Gabriel
    Moreno, Victor
    Simon, Iris
    Dreezen, Christa
    Lopez-Doriga, Adriana
    Santos, Cristina
    Marijnen, Corrie
    Westerga, Johan
    Bruin, Sjoerd
    Kerr, David
    Kuppen, Peter
    van de Velde, Cornelis
    Morreau, Hans
    Van Velthuysen, Loes
    Glas, Annuska M.
    Van't Veer, Laura J.
    Tollenaar, Rob
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (01) : 17 - 24
  • [44] Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer
    Xiao, Yitai
    Zhang, Guixiong
    Wang, Lizhu
    Liang, Mingzhu
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [45] Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics
    Liu, Xinlu
    Li, Na
    Zhang, Chi
    Wu, Xiaoyu
    Zhang, Shoujia
    Dong, Gang
    Liu, Ge
    TRANSLATIONAL ONCOLOGY, 2022, 19
  • [46] Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer
    Miura, Tomiyuki
    Ishiguro, Megumi
    Ishikawa, Toshiaki
    Okazaki, Satoshi
    Baba, Hironobu
    Kikuchi, Akifumi
    Yamauchi, Shinichi
    Matsuyama, Takatoshi
    Uetake, Hiroyuki
    Kinugasa, Yusuke
    ONCOLOGY LETTERS, 2020, 19 (01) : 229 - 238
  • [47] Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
    Zhang, Yichi
    Lin, Yifeng
    Lv, Daojun
    Wu, Xiangkun
    Li, Wenjie
    Wang, Xueqing
    Jiang, Dongmei
    PEERJ, 2022, 10
  • [48] Identification of Candidate Genes Associated with Breast Cancer Prognosis
    Xu, Yun-Hua
    Deng, Jun-Li
    Wang, Li-Ping
    Zhang, Hai-Bo
    Tang, Lu
    Huang, Ying
    Tang, Jie
    Wang, Shou-Man
    Wang, Guo
    DNA AND CELL BIOLOGY, 2020, 39 (07) : 1205 - 1227
  • [49] Identification and targeting of cancer-associated fibroblast signature genes for prognosis and therapy in Cutaneous melanoma
    Zhang, Guokun
    Ji, Pengfei
    Xia, Peng
    Song, Haoyun
    Guo, Zhao
    Hu, Xiaohui
    Guo, Yanan
    Yuan, Xinyi
    Song, Yanfeng
    Shen, Rong
    Wang, Degui
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 167
  • [50] An eight-long noncoding RNA expression signature for colorectal cancer patients' prognosis
    Zhang, Lin
    Chen, Shuo
    Wang, Boxue
    Su, Yinan
    Li, Shuyuan
    Liu, Guisheng
    Zhang, Xipeng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 5636 - 5643